Mischa Obshotkin (later Milton Upsher) was born in 1908 in Tarashcha, Ukraine – a small, rural town located south of Kyiv. Following WWI, his father’s earlier journey to America, and a pogrom in his village, Milton and his remaining family made a more than 2,000km trek, largely on foot, from Ukraine to Belgium in order to seek safe passage to New York City. Arriving in New York in 1923, Milton met his new apartment neighbor and future wife, Harlem, New York-born Ella Schumacher (born 1907). Milton, while not formally educated, was a dedicated worker and sought out employment as a Pharmacist’s Assistant during the Great Depression; Ella pursued a teaching degree at Hunter College.

In 1951, Milton was hired as a Chemist at Desitin Chemical Company – a pharmaceutical company specializing in ointments, creams, lotions, and suppositories. Ever an entrepreneur and a tinkerer, Milton became fixated on improving Desitin’s flagship ointment product for diaper rash. Originally sold as a thick, difficult-to-apply paste in a 1-lb. tube, Milton reformulated, repackaged, and relaunched the product as an easily dosed, highly efficacious cod oil-infused tube-packaged ointment. The relaunch proved immediately to be a dramatic commercial success; sales spiked, and the product reached complete ubiquity. Within the decade, Milton rose from a Chemist, to one of four divisional VPs, and, in 1958, succeeded Founder & CEO Edwin Speidel to lead the company. By 1963, the company had the leading market share product in each of the diaper rash, pediatric ‘dermatologicals’, and anti-fungal product categories.

In 1962, Chas. Pfizer & Co. Inc. began making overtures to buy Desitin Pharmaceutical; Pfizer, at the time, was $900MM market cap chemical company with a small portfolio of antibiotics that it had scaled up during World War II, but had ambitions to build a pharmaceutical and OTC product empire. In April 1963, the all-stock acquisition closed. In 1969, Milton and Ella Upsher set up the Upsher Management Company family office. While Milton passed away in 1974, Ella held the Pfizer position in its entirety for 40 years, ultimately turning over the keys to her grandson, Daniel Lubin, in 2003.

Daniel Lubin is Chairman of Upsher Management Company (UMC), a single-family office spanning five generations and built upon his family’s 85-year legacy as operators, clinicians and investors in the healthcare industry. Today, UMC manages a diversified portfolio of assets constructed around a number of core themes, including defense, energy, data, and advanced manufacturing.

Daniel has dedicated his career to investing in disruptive innovation. He co-founded and served as a Managing Partner of Radius Ventures LLC, a New York-based venture capital firm investing in leading-edge health and life sciences companies. In 2017, he co-founded Entrypoint Capital, an investment management firm pioneering the fusion of systematic quantitative processes and AI/machine learning with fundamentally driven thematic investing in publicly traded securities.

Daniel is a Trustee of the Center for the Study of the Presidency & Congress, and a member of the Board of International Councilors of the Harvard Kennedy School Belfer Center for Science & International Affairs. He previously served as a trustee of The Haverford School and Riverdale Country School, where he sat on the finance and investment committees. He also served as a CEO mentor to the Endless Frontier Lab (EFL) at New York University’s Stern School of Business.

Daniel is the Founder and Co-Chair of the Family Office Roundtable (FORT), a unique academic-family office membership community established in partnership with the University of Pennsylvania’s Wharton Global Family Alliance, which is hosting its 23rd annual meeting this November 2024 in Washington, DC. He recently launched and Co-Chairs the “Sherpa Salon” (Sherpa). Both FORT and the Sherpa are organized on the think tank model, bringing together single family offices from around the world to study the collision of geopolitics with the capital markets, and explore the impact on investment portfolio strategy and tactics.

Daniel earned a B.S. cum laude in Foreign Service from the Georgetown University School of Foreign Service and an M.B.A. with honors from Harvard Business School.